Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RZZ-Spindly and CENP-E form an integrated platform to recruit dynein to the kinetochore corona. | EMBO J | 2023 | 37984321 | PubTator, text mining | PubMed |
| HDAC activity is dispensable for repression of cell-cycle genes by DREAM and E2F:RB complexes. | bioRxiv | 2023 | 37961464 | PubTator, text mining | PubMed |
| Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma. | Int J Mol Sci | 2023 | 37958555 | PubTator, text mining | PubMed |
| Identification of a Complex Karyotype Signature with Clinical Implications in AML and MDS-EB Using Gene Expression Profiling. | Cancers (Basel) | 2023 | 37958462 | PubTator, text mining | PubMed |
| The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia. | Cancers (Basel) | 2023 | 37958340 | PubTator, text mining | PubMed |
| Cell cycle responses to Topoisomerase II inhibition: Molecular mechanisms and clinical implications. | J Cell Biol | 2023 | 37955972 | PubTator, text mining | PubMed |
| A robust six-gene prognostic signature based on two prognostic subtypes constructed by chromatin regulators is correlated with immunological features and therapeutic response in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37938151 | PubTator, text mining | PubMed |
| Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance. | J Transl Med | 2023 | 37936202 | PubTator, text mining | PubMed |
| Preneoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma. | Nat Commun | 2023 | 37932266 | PubTator, text mining | PubMed |
| Role of Kinetochore Scaffold 1 (KNL1) in Tumorigenesis and Tumor Immune Microenvironment in Pan-Cancer: Bioinformatics Analyses and Validation of Expression. | Int J Gen Med | 2023 | 37928953 | PubTator, text mining | PubMed |
| Kinome profiling identifies MARK3 and STK10 as potential therapeutic targets in uveal melanoma. | J Biol Chem | 2023 | 37923138 | PubTator, text mining | PubMed |
| Interplay between the DNA damage response and the life cycle of DNA tumor viruses. | Tumour Virus Res | 2023 | 37918513 | PubTator, text mining | PubMed |
| Unraveling the role of disulfidptosis-related LncRNAs in colon cancer: a prognostic indicator for immunotherapy response, chemotherapy sensitivity, and insights into cell death mechanisms. | Front Mol Biosci | 2023 | 37916187 | PubTator, text mining | PubMed |
| Identification of potentially functional circRNAs and prediction of the circRNA-miRNA-hub gene network in mice with primary blast lung injury. | BMC Pulm Med | 2023 | 37891516 | PubTator, text mining | PubMed |
| PLK1 promotes the mitotic surveillance pathway by controlling cytosolic 53BP1 availability. | EMBO Rep | 2023 | 37888778 | PubTator, text mining | PubMed |
| Exploring Plant Meiosis: Insights from the Kinetochore Perspective. | Curr Issues Mol Biol | 2023 | 37886947 | PubTator, text mining | PubMed |
| Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth. | Nat Commun | 2023 | 37880212 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Analysis of The Cell Division Cycle and Ribosomal Pathways in The Rat Varicocele: Implications for Drug Discovery. | Cell J | 2023 | 37865881 | PubTator, text mining | PubMed |
| Permission to pass: on the role of p53 as a gatekeeper for aneuploidy. | Chromosome Res | 2023 | 37864038 | PubTator, text mining | PubMed |
| The anti-tumor potential of sinomenine: a narrative review. | Transl Cancer Res | 2023 | 37859743 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=13